The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $99,524 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an unspecified government-wide acquisition contract vehicle. DMS Pharmaceutical will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, with performance required between August 1st and 22nd, 2023. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $24,881 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense. Park Ridge, Illinois is the place of performance for delivery of the 20mL vials, with work scheduled to be completed by July 27, 2023. No subcontractors or set aside designations were identified. The DLA manages the...
The Defense Logistics Agency awarded a $11,257 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DLA will receive 10 ML vials of the specified anesthetic to support its medical supply needs. As a leading provider of pharmaceuticals and medical supplies to the DOD, this award falls within DLA's mandate to ensure troops receive necessary medical products and treatments. No subcontractors or set aside designations were indicated. The single...
The Defense Logistics Agency awarded a $11,257 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DLA will receive 10 ML vials of the specified anesthetic to support DoD requirements. The single award was issued under an unspecified government-wide acquisition contract vehicle or blanket purchase agreement held by DMS. Work will be performed in Park Ridge, Illinois and must be completed by July 18, 2023. No socioeconomic designations or...
The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Funding is provided by DLA in support of Department of Defense requirements. The order has a period of performance from August 1, 2023 through August 22, 2023 and...
The Defense Logistics Agency awarded a $49,762 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order is for 20mL vials of the specified anesthetic and will be fulfilled from Park Ridge, Illinois by July 21, 2023 in support of Department of Defense requirements. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States military and this order is...
The Defense Logistics Agency awarded a $7,464 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DLA will receive 20mL vials of the specified anesthetic to support Department of Defense needs. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September 6th and 27th, 2023. No set aside designation or subcontractors were identified. DLA manages the military's supply chain as one of the largest logistics agencies,...
The Defense Logistics Agency awarded a delivery order valued at approximately $7,464 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. The order was issued against an existing DLA contract vehicle and has a period of performance from July 5, 2023 through July 26, 2023. As the...
The Defense Logistics Agency awarded a $3,390 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DLA will receive 10 ML vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension used for postsurgical analgesia, for use in supporting Department of Defense programs. Performance will occur in Park Ridge, Illinois over a three-week period concluding in late August. No set aside provisions or subcontractors were identified....
The Defense Logistics Agency awarded a $20,712 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense. DMS will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance by September 25, 2023. No set aside designation or subcontractors were identified. The Defense...